Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Thomson AW . The cytokine handbook, 2nd ed. San Diego: Academic Press, 1994.
Paul WE, Seder RA . Lymphocyte response and cytokines. Cell 1994;76:241.
Weiner HL, Freidman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809–37.
Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M, et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 1993;23:3096–103.
Calder VL, Hingorani M, Metz D, Buckley RJ, Lightman S . Differential expression of T cell cytokines in chronic allergic eye disease. Abstract book, Fourth International Symposium on Ocular Inflammation, London, UK 1996:34.
Cousins SW, McCabe MM, Danielpour D, Streilein W . Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1990;32:2201–11.
Streilen J, Bradley D, Sano Y . Immunosuppressive properties of tissues of the ocular anterior segment. Ocul Immunol Inflamm 1996;4:57–68.
de Vos AF, Hoekzema R, Kijlstra A . Cytokines and uveitis: a review. Curr Eye Res 1992;11:581–97.
Chandler JW, Heise ER, Weiser RS . Induction of delayed-type sensitivity-like reactions in the eye by the injection of lymphokines. Invest Ophthalmol Vis Sci 1973;12:400–9.
Liu SH, Prendergast RA, Silverstein AM . The role of lymphokines in immunogenic uveitis. Invest Ophthalmol Vis Sci 1983;24:361–7.
Benson MT, Shepherd L, Rees RC, Rennie IG . Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr Eye Res 1992;11:173–9.
Kuppner MC, McKillop-Smith S, Forrester JV . TGF-β and IL-1β act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology 1995;84:265–71.
Planck SR, Huang X-N, Robertson JE, Rosenbaum T . Retinal pigment epithelial cells produce interleukin-1 and granulocyte-macrophage colony-stimulating factor in response to interleukin-1. Curr Eye Res 1993; 3:205–12.
Einer VM, Strieter RM, Einer SG, Baggiolini M, Lindley I, Kunkel S . Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990;136:745–50.
Einer SG, Strieter RM, Einer VM, Rollins BJ, Del Monte MA, Kunkel SL . Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 1991;64:819–25.
Jaffe GJ, Van Le L, Valea F, Haskill S, Roberts W, Arend WP, Stuart A, Peters WP . Expression of interleukin-1, interleukin-1 and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res 1992;55:325–35.
Rosenbaum JT, Samples JR, Hefeneider SH, Howes EL . Ocular inflammatory effects of intravitreal interleukin 1. Arch Ophthalmol 1987;105:1117–20.
Hoekzema R, Murray PI, Kijlstra A . Cytokines and intraocular inflammation. Curr Eye Res 1990;9:207–11.
Kulkarni PS, Srinivasan BD . Cachectin: a novel polypeptide induces uveitis in the rabbit eye. Exp Eye Res 1988;46:631–3.
Ferrick MR, Thurau SR, Oppenheim MH, Herbort CR, Ni M, Zachariae COC, et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 1991;32:1534–9.
Bhattacherjee P, Henderson B . Inflammatory responses to intraocularly injected interleukin 1. Curr Eye Res 1987;6:929–34.
de Vos AF, Klaren VNA, Kijlstra A . Expression of multiple cytokines and interleukin-1 receptor antagonist in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994; 35:3873–83.
de Vos AF, van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A . Kinetics of intraocular tumour necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35:1100–6.
Lang RA, Cuthbertson RA, Dunn AR . TNF alpha, IL-1 alpha and bFGF are implicated in the complex disease of GM-CSF transgenic mice. Growth Factors 1992;6:131–8.
Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, Monahan-Earley RA, Galli SJ . Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice: evidence of mast cell histamine release in vivo by diamine oxidasegold enzyme-affinity ultrastructural cytochemistry. Blood 1994;83:3600–12.
Geiger K, Howes E, Gallina M, Huang XJ, Travis GH, Sarvetnick N . Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss. Invest Ophthalmol Vis Sci 1994;35:2667–81.
Geiger K, Howes EL, Sarvetnick N . Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections. J Virol 1994;68:5556–67.
Egwuagu CE, Sztein J, Chan CC, Reid W, Mahdi R, Nussenblatt RB, Chepelinsky AB . Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression. Invest Ophthalmol Vis Sci 1994;35:332–41.
Jones LS, Rizzo LV, Agarwal R, Silver PB, Caspi RR . Interferon gamma (IFN-γ) deficient mice are susceptible to induction of experimental autoimmune uveitis (EAU) [abstract]. Invest Ophthalmol Vis Sci 1996;37:S896.
Franks WA, Limb GA, Stanford MR, Ogilvie J, Wolstencroft RA, Chignell AH, Dumonde DC . Cytokines in human intraocular inflammation. Curr Eye Res 1992;11:187–91.
Wakefield D, Lloyd A . The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992;4:1–5.
Murray PI, Hoekzema R, van Haren MAC, de Hon FD, Kijlstra A . Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 1990;31:917–20.
de Boer JH, van Haren MAC, de Vries-Knoppert WAEJ, Baarsma GS, de Jong PVTM, Postema FJ, et al. Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res 1992;11:181–6.
de Boer JH, Hack CE, Verhoeven AJ, Baarsma GS, de Jong PTVM, Rademakers AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci 1993; 34:3376–85.
Mondino BJ, Sidikaro Y, Mayer FJ, Sumner HL . Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest Ophthalmol Vis Sci 1990;30:798–804.
Nishi O, Nishi K, Imanishi M . Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992;76:338–41.
vanderLelij A, Rothova A, de Vries JP, Vetter JCM, van Haren MAC, Stilma JS, Kijlstra A . Analysis of aqueous humour in ocular onchocerciasis. Curr Eye Res 1991;10:169–76.
Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P . Role of interleukin 6 in the inflammatory response after cataract surgery: an experimental and clinical study. Arch Ophthalmol 1991;109:1681–3.
Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME . Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994; 35:900–6.
Baggiolini M, Dahinden CA . CC chemokines in allergic inflammation. Immunol Today 1994;15:127–33.
Einer SG, Einer VM, Jaffe GJ, Stuart A, Kunkel SL, Streiter RM . Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995;14:1045–53.
Hooks JJ, Chan CC, Detrick B . Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci 1988;29:1444–51.
Chan CC, Scott M, Whitcup MD, Solomon D, Nussenblatt RB . Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995;120:671–3.
de Boer JH, Limpens J, Orengo-Nania S, de Jong PTVM, La Heij E, Kijlstra A . Low mature TGF-β2 levels in aqueous humor. Invest Ophthalmol Vis Sci 1994;35:3702–10.
Schultz MW, Chamberlain CG, McAvoy JW . Inhibition transforming growth factor-β-induced cataractous changes in lens expiants by ocular media and α2-macroglobulin. Invest Ophthalmol Vis Sci 1996;37:1509–19.
Arocker-Mettinger E, Asenbauer T, Ulbrich S, Grabner G . Serum interleukin 2-receptor levels in uveitis. Curr Eye Res 1990;9:25–9.
Ben Ezra D, Maftzir G, Kalichman I, Barak V . Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol 1993;115:26–30.
Limb GA, Chignell AH, Green W, Leroy F, Dumonde DC . Distribution of TNF-alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:168–73.
Suttorp-Schulten MSA, Jager MJ, Kijlstra A . Recent developments in the treatment of posterior uveitis. Ocul Immunol Inflamm 1996;4:207–17.
Nishi O, Nishi K, Ohmoto Y . Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation. Br J Ophthalmol 1994;78:917–20.
Rosenbaum JT, Angell E . Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 1995;155:4090–4.
Ramanathan S, de Kozak Y, Saoudi A, Goureau O, van der Meide PH, Druet P, Bellon B . Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996;157:2209–15.
Röcken M, Racke M, Shevach EM . IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996;17:225–31.
Feron EJ, Rothova A, van Hagen PM, Baarsma GS, Suttorp-Schulten MSA . Interferon-α2b for refractory ocular Behçet's disease. Lancet 1994;343:1428.
Caspi RR, Chan CC, Grubbs BG, Silver PB, Wiggert B, Parsa CF, Bahmanyar S, et al. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 1994;152:890–9.
Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis F, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36:1681–90.
Kasner L, Chan CC, Whitcup SM, Gery I . The paradoxical effect of tumor necrosis factor alpha (TNF-α) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1993;34:2911–7.
de Vos AF, van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A . Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res 1995;61:667–75.
